Non- Applicability of report on Corporate Governance pursuant to regulation 27(2) of the SEBI (LODR) Regulation, 2015.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
KMS Medisurgi Limited has informed BSE that it is not required to submit a quarterly Corporate Governance Report for the quarter ended 31st March 2025. The exemption applies because the company is listed on the BSE SME Platform, which under SEBI's LODR Regulation 15(2) relieves smaller listed entities from compliance with corporate governance provisions. The company meets the criteria for exemption as a SME-listed entity with paid-up equity capital not exceeding Rs. 10 crore and net worth not exceeding Rs. 25 crore. The letter is signed by Managing Director Siddharth Kanakia and submitted as a routine regulatory disclosure.
No impact on shareholders or stock price — this is a standard procedural filing confirming an exemption that applies to all SME-listed companies. Investors should note that KMS Medisurgi's corporate governance disclosures will be limited compared to main-board listed companies.